Brief: Evolus Says Daewoong Pharmaceutical to invest $40 Million in Co
07/07/2020 01:48
July 6 (Reuters) - Evolus Inc EOLS.O :
* EVOLUS STRENGTHENS BALANCE SHEET; SECURES $40 MILLION
INVESTMENT
* EVOLUS-DAEWOONG PHARMACEUTICAL CO WILL INVEST $40 MILLION
IN A
FIVE-YEAR, UNSECURED, SUBORDINATED, 3% CONVERTIBLE NOTE IN CO AT
A CONVERSION PRICE OF $13
* INVESTMENT BY DAEWOONG WILL BE FUNDED PRIOR TO JULY 31,
2020
Source text for Eikon: ID:nGNXbtYF3M
Further company coverage: EOLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daewoong Pharma
See all newsBrief: Daewoong Pharma Q2 Operating. Profit 77 Billion Won, Up 23% Y/Y
Brief: Daewoong Pharma Wins 92.6 Billion Won Order
Brief: Daewoong Pharma Q4 Operating Profit 45.5 Billion Won, Up 9% From Year Earlier
Brief: Daewoong Pharma Q2 Operating Profit 62.5 Billion Won, Up 26% From Year Earlier
Brief: Daewoong Pharma Q1 Operating Profit 42 Billion Won, Up 34.5% From Year Earlier